Product NDC: | 0168-0270 |
Proprietary Name: | Mometasone Furoate |
Non Proprietary Name: | mometasone furoate |
Active Ingredient(s): | 1 mg/g & nbsp; mometasone furoate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0270 |
Labeler Name: | E. Fougera & CO., A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076171 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050408 |
Package NDC: | 0168-0270-15 |
Package Description: | 15 g in 1 TUBE (0168-0270-15) |
NDC Code | 0168-0270-15 |
Proprietary Name | Mometasone Furoate |
Package Description | 15 g in 1 TUBE (0168-0270-15) |
Product NDC | 0168-0270 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | mometasone furoate |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20050408 |
Marketing Category Name | ANDA |
Labeler Name | E. Fougera & CO., A division of Fougera Pharmaceuticals Inc. |
Substance Name | MOMETASONE FUROATE |
Strength Number | 1 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |